Experience

Mariana Oncology

• Biotechnology Research
• 1 - 100 Employee

• Director

  • Nov 2022 - Present



Exo Therapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Principal Scientist

  • Mar 2022 - Nov 2022



Merck

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Associate Principal Scientist

  • May 2018 - Mar 2022

• Senior Scientist

  • May 2014 - May 2018



Calibr at Scripps Research

• United States
• Biotechnology Research
• 1 - 100 Employee

• Research Associate

  • Oct 2012 - Apr 2014

  Drug conjugates development for the treatment of metabolic diseases. Drug conjugates development for the treatment of metabolic diseases.



Scripps Research

• United States
• Research Services
• 700 & Above Employee

• Postdoctoral Research Associate

  • Sep 2012 - Apr 2014

  Drug conjugates development for the treatment of metabolic diseases under the supervision of Prof. Peter Schultz. Drug conjugates development for the treatment of metabolic diseases under the supervision of Prof. Peter Schultz.



University of Illinois Chicago

• United States
• Higher Education
• 700 & Above Employee

• Research Assistant, PhD

  • 2007 - Sep 2012

  Methodology development under the supervision of Prof. Vladimir Gevorgyan. • Invented a new chemical reagent for directed C-H functionalizations: PyDipSiH (Sigma-Aldrich® catalog No. 749605). • Pioneered the traceless/modifiable silicon-tether concept for C–H activation reactions. This concept allows developing a series of novel reactions (including arylation, alkylation, olefination, oxygenation, and halogenation) for the synthesis of valuable materials and bioactive molecules. •… Show more Methodology development under the supervision of Prof. Vladimir Gevorgyan. • Invented a new chemical reagent for directed C-H functionalizations: PyDipSiH (Sigma-Aldrich® catalog No. 749605). • Pioneered the traceless/modifiable silicon-tether concept for C–H activation reactions. This concept allows developing a series of novel reactions (including arylation, alkylation, olefination, oxygenation, and halogenation) for the synthesis of valuable materials and bioactive molecules. • Trained junior graduate students in the lab to become independent researchers. • Responsible for GCMS maintenance. • Chemical Hygiene Officer. Show less Methodology development under the supervision of Prof. Vladimir Gevorgyan. • Invented a new chemical reagent for directed C-H functionalizations: PyDipSiH (Sigma-Aldrich® catalog No. 749605). • Pioneered the traceless/modifiable silicon-tether concept for C–H activation reactions. This concept allows developing a series of novel reactions (including arylation, alkylation, olefination, oxygenation, and halogenation) for the synthesis of valuable materials and bioactive molecules. •… Show more Methodology development under the supervision of Prof. Vladimir Gevorgyan. • Invented a new chemical reagent for directed C-H functionalizations: PyDipSiH (Sigma-Aldrich® catalog No. 749605). • Pioneered the traceless/modifiable silicon-tether concept for C–H activation reactions. This concept allows developing a series of novel reactions (including arylation, alkylation, olefination, oxygenation, and halogenation) for the synthesis of valuable materials and bioactive molecules. • Trained junior graduate students in the lab to become independent researchers. • Responsible for GCMS maintenance. • Chemical Hygiene Officer. Show less



Nanjing University

• China
• Higher Education
• 700 & Above Employee

• M.S.

  • 2004 - 2007

  Inorganic Chemistry; Coordination Chemistry, Supermolecular Self-Assembly • Discovered a copper mediated C-S bond cleavage reaction; validated reaction mechanism with X-ray crystallography and MS analysis. • Teaching: General chemistry experiments (labs).

• B.S.

  • 2000 - 2004

  Chemistry